JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: 'signaling pathways cardiovascular {{media url='

Search results for: 'signaling pathways cardiovascular {{media url='

A8246 BEZ235 (NVP-BEZ235)
2 Citation

Summary: PI3K/mTOR inhibitor,ATP-competitve

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
A8250 LY 294002
16 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A2067 PI-103
1 Citation

Summary: Class I PI3K, mTOR and DNA-PK inhibitor

≥21.9 mg/mL
A5112 XL147

Target: PI3K

Summary: PI3K inhibitor,selective and reversible

≥22.45 mg/mL
A2681 TGX-221

Target: PI3K

Summary: PI3Kβ inhibitor,potent,selective and ATP competitive

insoluble in H2O; insoluble in EtOH; ≥68.7 mg/mL
A5078 KU-0063794

Target: mTOR

Summary: MTORC1 and mTORC2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.65 mg/mL
A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A1266 WYE-354

Summary: MTOR inhibitor,potent,ATP-competitive and cell-permeable

≥49.6 mg/mL
A2754 TG100-115

Target: PI3K

Summary: PI3Kγ/PI3Kδ inhibitor

insoluble in H2O; insoluble in EtOH; ≥3.46 mg/mL
A2764 PIK-90

Summary: PI3K inhibitor,potent selective

insoluble in DMSO